HHS should ensure 340B hospitals remain eligible despite changes in payer mix, AHA says
Hospitals participating in the 340B Drug Pricing Program could lose access due to payer mix changes stemming from the COVID-19 pandemic unless HHS issues a waiver.
News briefs: The new COVID-19 relief legislation could result in a big Medicare payment cut
The $1.9 trillion American Rescue Plan, which was signed into law March 11, could lead to a significant reduction in Medicare revenues if Congress does not act.
How a health system prepared to comply with CMS’s new price transparency rule
The efforts of one health system to meet state and federal price transparency regulations shows the benefit of integrating transparency efforts into a broader organizational strategy.
Hospitals can use new CMS Condition of Participation regarding ADTs to enhance strategic alignment with independent physicians and post-acute providers
New requirements regarding notifications of admissions, discharges and transfers present both a challenge and a strategic opportunities for hospitals.
Report: Large sampling reveals 30% of hospitals haven’t complied with any aspect of the new price transparency requirements
Hospitals have had an easier time posting the required price information for consumer-friendly shoppable services than for all the services in their chargemaster, according to a large survey.
Price transparency: the next chapter
HFMA President and CEO Joe Fifer discusses the latest developments in the societal movement toward full price transparency in healthcare.
HHS postpones deadline for hospitals to comply with Provider Relief Fund reporting requirements
With new legislation having modified the rules governing the reporting of Provider Relief Fund payments, HHS has indefinitely postponed the Feb. 15 reporting deadline.
New legislation seeks to take unwelcome surprises out of patient billing
A new law called The No Surprises Act is designed to prevent healthcare consumers from getting stuck with potentially large bills after receiving out-of-network care.
How to develop a winning pricing strategy in the post-COVID-19 consumer market
Providers and health plans should prepare for federally imposed price transparency mandates imposed by developing comprehensive pricing strategies tailored to their specific market positions, financials and operational objectives.
Price transparency as a guiding principle: directionally correct
HFMA President and CEO Joe Fifer offers a perspective on HFMA’s approach to price transparency vis-à-vis the upcoming CMS regulations on payment rate transparency.